22157.jpg
Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (ONLINE EVENT: May 19-20, 2025/ON-DEMAND))
September 18, 2024 11:18 ET | Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training...
Biora-tm_rgb.jpg
Biora Therapeutics Achieves ISO 13485 Certification
September 09, 2024 08:00 ET | Biora Therapeutics, Inc.
ISO certification underscores the company’s commitment to quality and excellence
22157.jpg
Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (LIVE EVENT: January 21-22, 2025 AND ON-DEMAND)
September 06, 2024 06:51 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training...
22157.jpg
2 Day Virtual Workshop: Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course
September 06, 2024 06:42 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course 24" conference has been added to ...
Drug Eluting Balloons (DEBs) Market
Drug-Eluting Balloons (DEBs) Market Assessment 2024-2030 - Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
September 05, 2024 05:00 ET | Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Drug Eluting Balloons (DEBs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
U.S. Generic Drugs Market
United States Generic Drugs Market Analysis Report 2024-2032: Reimbursement and Lower Co-payments, Patent Expiry of Blockbuster Drugs, Incentives for Dispensing and Prescribing Generic Drugs
August 06, 2024 04:03 ET | Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market Report By Therapeutic Area, Type, Drug Delivery, Age Group, Distribution Channel, Payment Type, States and Company...
Medical Disposable Products Market to Reach $857.0 Billion, Globally, by 2033 at 6% CAGR: Allied Market Research
August 05, 2024 10:41 ET | Allied Analytics LLP
Wilmington, Delaware, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Medical Disposable Products Market by Product (Wound Management Products, Drug Delivery...
Drug Delivery Market
Global Drug Delivery Market Poised for Considerable Growth, Projected to Reach US$1,516.944 Billion by 2029
August 02, 2024 09:03 ET | Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The global drug delivery market...
Global Chinese Drug Delivery Market
China Drug Delivery Market Research 2024 with Competitive Analysis of Gerresheimer, Pfizer, Shanghai Fosun Pharmaceutical, Hutchison China MediTech, GL Montrose, & Becton, Dickinson and Co
July 02, 2024 07:51 ET | Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "China Drug Delivery Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The China drug delivery market is...
NurExone logo2.png
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
June 21, 2024 16:04 ET | NurExone Biologic Inc
TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,...